Results 121 to 130 of about 723,902 (263)
Immunofluorescence in immunobullous diseases
, 2017 Immunofluorescence has become an essential component of today’s dermatological laboratory. During the last four decades, innovations in this field have revolutionized the concepts about the pathogenesis, diagnosis and differential diagnosis of autoimmune
Ijaz Hussain, Zahida Rani
core +1 more source
FEBS Open Bio, EarlyView.Glioblastoma cells express calcitonin receptor variants (CT receptor isoforms) that may help them survive stress. Using qPCR, transcript‐specific long‐read nanopore sequencing, immunofluorescence co‐localisation and comparative sequence analysis, this study identifies a novel alternatively spliced CALCR transcript that encodes the CTb receptor isoform ...
Pragya Gupta +7 more
wiley +1 more source
Immunofluorescence Triple Lindy
, 2012 Presentation on Immunofluorescence techniques given at the 38th NSH Annual Symposium and Conference, Sept 30, 2012 in Vancouver ...
Randolph-Habecker, Julie +2 more
core
FEBS Open Bio, EarlyView.TGF‐β1 stimulation downregulates lysosomal channel TRPML1 in pulmonary fibroblasts. The TRPML1 agonist ML‐SA5 suppressed fibroblast‐to‐myofibroblast activation and collagen production. Mechanistically, ML‐SA5 inhibited mTOR phosphorylation, restored autophagic flux, and its effects were enhanced by rapamycin (mTOR inhibitor) and reversed by MHY1485 ...
Jiatong Yao +10 more
wiley +1 more source
Direct immunofluorescence findings - pyoderma gangrenosum
Pyoderma gangrenosum direct immunofluorescence ...
Lehman, Julia
core +1 more source
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Objective To evaluate the efficacy and safety of ofatumumab in patients with myelin oligodendrocyte glycoprotein antibody–associated disease (MOGAD), and compare it with rituximab. Methods We conducted a single–center, observational study including 22 MOGAD patients treated with ofatumumab and 21 treated with rituximab.
Yuxin Fan +5 more
wiley +1 more source
Binding activity measured by immunofluorescence.
, 2013 Binding activity measured by immunofluorescence.
Robert H. Purcell (284615) +7 more
core +1 more source
Early Clinical, Imaging, and Pathological Characteristics of SRPK3/TTN‐Digenic Myopathy
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Objective SRPK3/TTN‐digenic myopathy was recently established as a skeletal muscle myopathy caused by digenic inheritance. This study characterizes the early clinical presentation of SRPK3/TTN‐digenic myopathy in one previously reported and seven newly identified pediatric patients.
Rotem Orbach +23 more
wiley +1 more source
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Background Factors associated with relapse course and disability in myelin oligodendrocyte glycoprotein antibody‐associated disease (MOGAD) remain incompletely understood. Objectives To identify clinical and modifiable factors associated with relapse and disability in MOGAD. Methods In this ambispective multicentre cohort study using data from
Yingtao Wang +23 more
wiley +1 more source
Immunofluorescence of strain Manara.
, 2016 Immunofluorescence of strain Manara isolated from a kidney sample of a Southern right whale (Eubalaena australis) 40X.
Graciela Romero (841174) +6 more
core +1 more source